Physician profile
Kinjal B Sohagia
NPI 1013174523
$7,782.95
in general payments reported to CMS, 2019-2025
26 companies · $3,453 in 2025
The $3,453 reported for 2025 was more than what 97% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $304 · 2021: $309 · 2022: $642 · 2023: $782 · 2024: $1,815 · 2025: $3,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,060 · Food and Beverage: $2,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,059.68 |
| Food and Beverage | $2,990.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,281.13 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Curonix LLC | $1,028.03 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $964.51 | 2019-2025 | Proclaim, Infinity, Axium |
| Collegium Pharmaceutical, INC. | $604.27 | 2019-2024 | Xtampza, Belbuca |
| Globus Medical, INC. | $547.81 | 2025 | Senza, Reline, Tlx |
| Nevro Corp. | $528.96 | 2020-2024 | Senza |
| Boston Scientific Corporation | $149.72 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $99.20 | 2019-2021 | |
| Allergan, INC. | $71.97 | 2019-2021 | |
| Pacira Therapeutics, INC. | $63.42 | 2019 | |
| Electronic Waveform Lab, INC. | $54.10 | 2022-2023 | |
| Si-Bone, INC. | $53.33 | 2019 | |
| Fidia Pharma USA INC. | $40.54 | 2019-2024 | Hymovis |
| Biodelivery Sciences International, INC. | $37.65 | 2020-2021 | |
| Kaleo, INC. | $32.04 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $28.86 | 2019-2022 | |
| Trice Medical, INC. | $28.58 | 2022 | |
| Horizon Therapeutics Plc | $23.28 | 2020 | |
| Fortis Surgical, LLC | $22.66 | 2025 | |
| Abbvie INC. | $22.31 | 2023 | Botox |
| Pernix Therapeutics Holdings, INC. | $19.86 | 2019 | |
| Painteq LLC | $18.99 | 2024 | Painteq |
| Lundbeck LLC | $17.07 | 2023 | Vyepti |
| Vertical Pharmaceuticals, LLC | $16.32 | 2019 | |
| Pfizer INC. | $16.25 | 2021 | |
| Zyla Life Sciences, INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinjal Sohagia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.